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Summary
The rapamycin-insensitivemTOR complex 2 (mTORC2)
has been suggested to play an important role in
growth factor-dependent signaling. To explore this
possibility further in a mammalian model system, we
disrupted the expression of rictor, a specific compo-
nent of mTORC2, in mice by using a multiallelic gene
targeting strategy. Embryos that lack rictor develop
normally until E9.5, and then exhibit growth arrest
and die by E11.5. Although placental defects occur in
null embryos, an epiblast-specific knockout of rictor
only delayed lethality by a few days, thereby suggest-
ing other important roles for this complex in the
embryo proper. Analyses of rictor null embryos and
fibroblasts indicate that mTORC2 is a primary kinase
for Ser473 of Akt/PKB. Rictor null fibroblasts exhibit
low proliferation rates, impaired Akt/PKB activity,
and diminished metabolic activity. Taken together,
these findings indicate that both rictor and mTORC2
are essential for the development of both embryonic
and extraembryonic tissues.
Introduction
The mammalian target of rapamycin (mTOR), an evolu-
tionarily conserved serine/threonine kinase, plays a cen-
tral role in the regulation of cell growth and proliferation
(for reviews, see Harris and Lawrence, 2003; Jacinto and
Hall, 2003). mTOR exists in two multiprotein complexes
that have distinct biological functions (Inoki and Guan,
2006; Wullschleger et al., 2006). mTOR complex 1
(mTORC1), which is inhibited by the immunosuppres-
sant rapamycin, consists of mTOR, mLST8 (also known
as GbL), and raptor (Hara et al., 2002; Kim et al., 2002;
Loewith et al., 2002), while mTOR complex 2 (mTORC2),
which is not inhibited acutely by rapamycin (Sarbassov
et al., 2006), is comprised of mTOR, mLST8, and rictor
(also known as mAVO3) (Jacinto et al., 2004; Sarbassov
et al., 2004).
Studies of mTORC1, often relying on the use of rapa-
mycin to inhibit function, have shown that this complex
is essential for regulating cell growth in response to
both nutrients and growth factors. Signaling through
mTORC1 promotes protein synthesis through the inacti-
vation of the translation repressor 4E-BP1 and through
the activation of S6 kinase (S6K1) (for review, see Hay
and Sonenberg, 2004). Raptor, a positive regulator of
mTOR, appears to serve as an adaptor protein that
*Correspondence: mark.magnuson@vanderbilt.edurecruits mTOR substrates (Beugnet et al., 2003; Choi
et al., 2003; Nojima et al., 2003; Schalm et al., 2003). Until
recently, our knowledge of the functions of mTORC2
lagged behind that of mTORC1. However, the demon-
stration that mTORC2 phosphorylates Akt/protein ki-
nase B (PKB) on Ser473 in a growth factor-dependent
manner suggests that this complex may also have
some vitally important functions (Hresko and Mueckler,
2005; Sarbassov et al., 2005).
Akt/PKB, which is activated in a phosphatidylinositol
3-kinase (PI3K)-dependent manner, is a key intracellular
mediator of diverse cellular processes, including metab-
olism, gene expression, cell migration, angiogenesis,
proliferation, and cell survival (for reviews, see Brazil
et al., 2004; Whiteman et al., 2002). Full activation of
Akt/PKB requires phosphorylation at both Thr308 of
the activation loop by phosphoinositide-dependent
kinase 1 (PDK1) and Ser473 in the hydrophobic motif
(HM) of the C-terminal tail by another kinase(s) tentatively
named HM kinase or PDK2 (for a review, see Dong and
Liu, 2005). Since mTORC1 is a downstream target of
Akt/PKB, the finding that mTORC2 has HM kinase activ-
ity suggests that the functional interactions between
mTOR and the PI3K-Akt/PKB pathway are both more
significant and complex than previously thought.
To explore the function of mTORC2 in a mammalian
model system, we designed and used a gene-targeting
strategy that enabled us to generate mice with four
different allelic variants of the rictor gene locus from
a single homologous recombination event in mouse em-
bryonic stem cells. Our studies clearly demonstrate that
mTORC2 is critical for the phosphorylation of Akt/PKB
at Ser473 during embryogenesis, and that rictor is es-
sential for normal growth and development of the mouse
embryo.
Results
Multiallelic Gene Targeting and Sites of rictor
Expression
The cloning of a mouse rictor cDNA and targeting of the
rictor gene (Figures S1A–S1C) are described in the Sup-
plemental Data available with this article online. Begin-
ning with mice containing the parental riclacZ+neo allele,
the recombinase-mediated gene conversion strategy
shown in Figure 1A was used to generate three additional
allelic variants: riclacZ, ricEx3cond, and ricEx3del. Mice that
were heterozygous for riclacZ+neo were used to assess
both the temporal and spatial patterns of rictor gene ex-
pression. b-galactosidase (b-gal) staining of fetuses at
embryonic day 9.5 (E9.5) revealed strong and ubiquitous
lacZ expression (Figure S2A). Staining of E13.5 embry-
onic sections further showed that all developing organs
expressed lacZ, although with different levels of expres-
sion (Figure S2B). Similar results were obtained from all
embryos examined at E8.5–E16.5. In adult mice, lacZ
expression was observed strongly in the brain and testis
(Figures S2C–S2E); moderately in the spleen, liver, kid-
ney, and pancreas (Figure S2F); and more weakly in the
lung, skeletal muscle, heart, and urinary bladder. In brain
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584Figure 1. rictor Gene Disruption Leads to
Growth Arrest and Embryonic Lethality
(A) Diagram of the recombinase-mediated
gene conversion strategy and the structure
of four different allelic variants of the rictor
gene. The parental riclacZ+neo allele generated
by gene targeting contains both a lacZ cas-
sette fused to exon 3 and an intact exon 3.
(B) Wild-type and riclacZ+neo/lacZ+neo embryos
at E14.5. The riclacZ+neo/lacZ+neo embryo ex-
hibits hydrops fetalis.
(C) Real-time PCR analysis showing a
small amount of expression of rictor in
riclacZ+neo/lacZ+neo embryos. Results are
means6 SD of samples in duplicate. The as-
terisk indicates that no signal was detected.
(D) Level of rictor protein in wild-type (ric+/+),
heterozygous (ric+/2), and homozygous
(ric2/2) embryos at E10.5. Western blots
were performed with an anti-rictor antibody.
(E) Embryos that were homozygous for the
rictor conditional allele (ricEx3cond/Ex3cond),
heterozygous for the rictor null allele
(ricEx3cond/lacZ), and homozygous for the rictor
null allele (ricEx3del/lacZ) with b-gal staining at
E9.5.
(F) rictor conditional (ricEx3cond/Ex3cond) and
null (ricEx3del/lacZ) embryos at E10.5.
(G) Toluidine blue-stained resin sections
from control (ricEx3cond/w) and rictor null
(ricEx3del/Ex3del) embryos at E10.5. VZ, ventric-
ular zone of the neuroepithelium; MZ, mar-
ginal zone of the neuroepithelium; M, mesen-
chymal cell; B, blood cell.
The scale bars are 5 mm in (B), 1 mm in (E) and
(F), and 10 mm in (G).sections, strong staining was seen in neurons, but not
in glial cells (Figure S2D).
rictor Is Essential for Fetal Development
To determine the effect of the absence of rictor, we
sought to obtain pups that were homozygous for the
riclacZ+neo allele by performing heterozygote inter-
crosses. Since none of the 137 offspring born from
heterozygote intercrosses were of the homozygous ge-
notype, we began assessing embryonic survival at dif-
ferent times during development. Expected Mendelian
distribution ratios were observed in embryos isolated
by E11.5; however, embryonic lethality was observed
at later times, and the proportion of homozygous em-
bryos declined such that only 1 live embryo was identi-
fied among 44 embryos at E16.5 (see Table S1). Homo-
zygous riclacZ+neo embryos were indistinguishable,
based on appearance and size, from either wild-type
or heterozygous littermates prior to E12.5, but they oftendisplayed hydrops fetalis at later stages (Figure 1B). His-
tological analysis of homozygous riclacZ+neo embryos
isolated at various times did not reveal any major struc-
tural defects in any organ systems.
The variable time of death in embryos homozygous for
the riclacZ+neo allele prompted us to test by quantitative
PCR analysis whether this allele, which contained an in-
tact exon 3, was in fact null. Indeed, the presence of a
small amount of intact rictor mRNA in embryos homozy-
gous for riclacZ+neo, as shown in Figure 1C, indicated that
this allele was hypomorphic. In contrast to the riclacZ+neo
allele, both the ricEx3del and riclacZ alleles are expected to
be truly null because the removal of exon 3 shifts the
reading frame. Consistent with this, Western blot analy-
sis of protein extracts from embryos homozygous for
the ricEx3del allele, or of embryos that were compound
heterozygous for the ricEx3del and riclacZ alleles, did not
demonstrate any rictor protein (Figure 1D). Rictor null
embryos were indistinguishable from either wild-type
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E10.5, most rictor null embryos were smaller than their
wild-type littermates and showed growth arrest begin-
ning between E9.5 and E10.5 (Figure 1F). Live embryos
were not observed at E11.5 or later (see Table S2). His-
tological analysis of rictor null embryos at E10.5 did
not show any disturbances in gross structure. However,
at the cellular level, hydropic changes, evident by nu-
clear swelling and formation of vacuoles, were seen in
neural epithelial cells, cardiac myocytes, endothelial
cells, and mesenchymal cells, thereby indicating that
cellular degeneration was occurring (Figure 1G).
Placental Defects in rictor Null Mice
The presence of a defective placenta during develop-
ment is among the most common causes of embryonic
lethality in midgestation (Rossant and Cross, 2001). The
absence or insufficiency of a functional interface be-
tween the maternal and fetal circulation results in a
shortage of oxygen and nutrients to the embryo. Since
rictor is also expressed in the fetal placenta (Figure 2A),
and since the rictor null embryos displayed diffuse hy-
dropic changes, we examined whether the placental de-
fect was a possible mechanism of lethality in rictor null
embryos. Analysis of the placenta from an E16.5 hypo-
morphic mutant showed that the riclacZ+neo/lacZ+neo pla-
centa was both smaller and thinner than the wild-type lit-
termate placenta. The fetal part of the riclacZ+neo/lacZ+neo
placenta was observed to consist of three layers—giant
cell, spongiotrophoblast, and labyrinth layers—as seen
in normal placentas. However, in situ hybridization anal-
ysis of placental lactogen I (PL-1) expression, which
serves as a marker for trophoblast giant cells (Colosi
et al., 1987), revealed that they were both increased in
number and aberrantly distributed throughout the laby-
rinth layer (Figures 2B and 2C). Although the labyrinth
layer was observed to be forming in both the control
and rictor null placentas at E10.5 (Figures 2D and 2E),
and numerous maternal fetal interfaces were evident in
the controls (Figure 2F), this layer remained cell dense
and exhibited fewer maternal-fatal interfaces in most
rictor null placentas (Figure 2G).
Epiblast-Specific Knockout of rictor
Although a placental defect might partially account for
the midgestational lethality, our finding that rictor is
highly expressed in the embryo proper prompted us to
perform an epiblast-specific knockout with the condi-
tional ricEx3cond allele. Since mesenchyme homeobox 2
(Meox2)-cre mice express Cre only in epiblast-derived
tissues (i.e., embryo proper and extraembryonic meso-
derm), and since the cre knockin allele in these animals
has been shown to promote high-efficiency recombina-
tion (Tallquist and Soriano, 2000), interbreeding with
this strain enabled us to test whether maintaining rictor
expression in the placenta might circumvent midgesta-
tional lethality in rictor null embryos. Although live ho-
mozygous ricEx3del embryos were obtained at E13.5
and E17.5, the number of those embryos was signifi-
cantly lower than expected from Mendelian distribution
(see Table S3). Moreover, no ricEx3del/Ex3del animals were
found at the time of weaning. Taken together, these
results suggest that rictor also has vital roles in the
embryo proper, not just in the placenta.Reduced Phosphorylation of the Akt/PKB
HM Site in rictor Null Embryos
Recent reports have indicated that mTORC2 is the
Ser473 kinase for Akt/PKB in several human cancer
cell lines (Sarbassov et al., 2005) and in a mouse adipo-
cyte cell line (Hresko and Mueckler, 2005). To determine
whether this is the case in vivo, Akt/PKB phosphoryla-
tion was examined in whole-body extracts from wild-
type and rictor null embryos obtained at E9.5 and
E10.5. Compared to the wild-type, rictor null embryos
exhibited only very low levels of phosphorylation of
Akt/PKB on Ser473, while a similar amount of phosphor-
ylation was detected on Thr308 (Figure 3). Despite
Figure 2. rictor Disruption Causes Developmental Abnormalities in
the Labyrinth Layer of the Placenta
(A) Whole-mount b-gal staining of placenta from a ricEx3cond/lacZ em-
bryo with maternal decidua (dec) (genotype of dam, ricEx3cond/Ex3del)
at E9.5 demonstrating strong expression of the rictor gene in fetal
placenta (asterisk) and yolk sac (arrows).
(B and C) In situ hybridization forPL-1 on sections from (B) ricw/w and
(C) riclacZ+neo/lacZ+neo placentas at E16.5. sp, spongiotrophoblast; lb,
labyrinth layer.
(D and E) Immunostaining for glucose transporter 1 (Glut1) on sec-
tions from (D) ricEx3cond/w and (E) ricEx3del/Ex3del placentas at E10.5.
Glut1 staining marks the syncytiotrophoblast in the labyrinth layer.
The border of the fetal placenta is shown by a dashed line. d, de-
cidua; g, giant trophoblast layer; sp, spongiotrophoblast layer; ch,
chorionic plate.
(F and G) Hematoxylin and eosin staining of the labyrinth layer (lb) of
(F) ricEx3cond/Ex3cond and (G) ricEx3del/lacZ placentas at E10.5. ch, cho-
rionic plate; g, giant trophoblast; m, maternal blood cells; f, fetal
blood cells (nucleated).
The scale bars are 1 mm in (A) and 100 mm in (B)–(G).
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586impaired phosphorylation of Ser473 in Akt/PKB, the
phosphorylation of Ser9 in GSK3b, which is a well-de-
fined substrate for Akt/PKB, was increased in rictor
null embryos. The amounts of mTOR protein, phosphor-
ylation of mTOR on Ser2448, and phosphorylation of
S6K1 on Thr389 were all similar in the wild-type and
rictor null embryos, thereby suggesting that Akt/PKB
remains active, or at least partially so, in rictor null
embryos.
Slow Growth and Impaired Metabolic Activity
of rictor Null Fibroblasts
To further characterize the consequences of a loss of
rictor, we isolated mouse embryonic fibroblasts
(MEFs) from E9.5 embryos. Although no noticeable dif-
ferences in morphology between wild-type and rictor
null MEFs were observed (Figure 4A), the growth rate
of rictor null cells was slower than that of wild-type
counterparts. To verify this, we established two sponta-
neously immortalized ricEx3del/Ex3del and ricEx3cond/w MEF
cell lines through extended culture and used them to
compare cellular proliferation rates. The cells lacking
rictor exhibited about a 50% lower basal incorporation
of BrdU than the control cells but responded to serum
or PDGF to a similar extent (Figure 4B). In addition, we
used the tetrazolium dye XTT, which measures the inte-
grated pyridine nucleotide redox status of cells, to as-
sess overall metabolic activity (Berridge et al., 2005)
and found the rictor null cells to be functionally impaired
(Figure 4C).
Impaired Activation of Akt/PKB by Growth Factors
in rictor Null Fibroblasts
Since growth factor signaling through tyrosine kinase
receptors leads to an increase in Akt/PKB phosphoryla-
Figure 3. rictor Disruption Reduces Phosphorylation of Akt/PKB on
Ser473
Total lysates were prepared from pools of rictor wild-type and
conditional embryos as a control (ric+/+) or from rictor null (ric2/2)
embryos at E9.75 and 10.5. Proteins indicated were detected by
Western blotting.tion, we tested the effects of both IGF-1 and PDGF, two
important factors for embryonic development (Baker
et al., 1993; Betsholtz, 2004), on Akt/PKB phosphoryla-
tion in rictor null MEFs. Wild-type (ricEx3cond/w) MEFs
showed a rapid increase in the phosphorylation of
Ser473 in response to either IGF-1 or PDGF (Figures
4D and 4E). In contrast, the phosphorylation of Ser473
in response to either IGF-1 or PDGF was markedly di-
minished in rictor null MEFs. The phosphorylation of
Thr308 in response to these growth factors was similar
in both the rictor null and control MEFs. Furthermore,
the phosphorylation of both S6 ribosomal protein and
p42/44 mitogen-activated protein kinase (MAPK) was
increased upon growth factor stimulation in both MEF
lines.
Finally, to test whether rictor null MEFs possessed
Akt/PKB activity, we performed an in vitro kinase assay
with paramyosin-GSK3a/b fusion protein as a substrate.
As was the case for the IGF-1- and PDGF-stimulated
cells, Thr308 phosphorylation was observed to occur
in response to serum stimulation for both the rictor
null and control MEFs. In contrast, while serum stimula-
tion caused a substantial increase in Akt/PKB kinase ac-
tivity in the wild-type MEFs, the response was reduced
by about half in the rictor null MEFs (Figure 4F).
Discussion
We have utilized four different allelic variants of the mu-
rine rictor gene to gain new, to our knowledge, insights
into the function of this gene, and consequently of
mTORC2, in animals. Experiments with these different
alleles allowed us to determine the sites of expression
and the consequences in the whole animal of disrupting
the expression of rictor, in both a global and cell-specific
manner. Disruption of the rictor gene is assumed to pre-
vent assembly of mTORC2. However, it is not known
whether rictor might also form complexes with other
proteins besides mTOR, or if it has independent func-
tions. On account of this, we are unable to distinguish
between the biological actions of rictor itself, if they
exist, and those of mTORC2.
mTORC2 as an Akt/PKB HM Kinase
The phosphorylation of Akt/PKB at Ser473 was dramat-
ically reduced in rictor null embryos. These data confirm
the previous finding of mTORC2 as an HM kinase in sev-
eral cell lines and, more importantly, show the relevance
of this function of mTORC2 in animals. However, while
our results indicate that mTORC2 is the dominant kinase
for Ser473 of Akt/PKB during embryogenesis, they also
point to the existence of other HM kinases, as has been
previously suggested (Dong and Liu, 2005).
Full activation of Akt/PKB is thought to require phos-
phorylation of both Thr308 and Ser473. Consistent with
this notion, we observed an impairment in Akt/PKB ac-
tivity in serum-stimulated rictor null MEFs, which ap-
pears to be the result of reduced Ser473 phosphoryla-
tion since Thr308 phosphorylation was unaffected.
Although several previous studies have suggested that
Ser473 phosphorylation is required for PDK1-mediated
phosphorylation of Thr308 (Sarbassov et al., 2005;
Scheid et al., 2002), our data indicate that the phosphor-
ylation of these two sites occurs independently.
rictor Knockout Mice
587Figure 4. rictor-Deficient MEFs Show Reduced Growth Rate, Metabolic Activity, and Growth Factor Signaling
(A) Phalloidin staining for F-actin in the control (ricEx3cond/w) and rictor null (ricEx3del/Ex3del) MEFs. The scale bar is 100 mm.
(B) Cell proliferation assay. The control or rictor null MEFs were incubated with BrdU in the presence of indicated concentrations of serum and
PDGF. BrdU incorporation was measured by ELISA assay. Data are represented as means6 SD of triplicate determinants. Similar results were
obtained in three independent experiments. **p < 0.01.
(C) XTT assay for metabolic activity of MEFs. The formation of formazan dye from XTT in the indicated number of control or rictor null cells was
monitored by the absorbance. Data are represented as means 6 SD of six determinations. Similar results were obtained in three independent
experiments. **p < 0.01.
(D and E) Phosphorylation of Akt/PKB and MAPK in the control or rictor null MEFs in response to growth factors. Cells were treated with (D) 50 ng/ml
IGF-1 or (F) 20 ng/ml PDGF for the indicated times. The indicated phosphoproteins were detected by Western blotting. eIF4E was included as
a protein loading control.
(F) In vitro kinase assay. Akt/PKB was immunoprecipitated from lysates of control or rictor null cells with or without serum stimulation and was
incubated with substrate GSK3a/b. Phosphorylated GSK3a/b was detected by Western blotting. Phosphorylation of Thr308 on Akt/PKB de-
tected by Western blotting is also shown. In this experiment, nonphosphorylated Akt/PKB was also detected by crossreaction of the antibody;
thus, it appears at a slightly lower position than the phosphorylated proteins.Embryonic Lethality in rictor Null Mice
The marked decrease in phosphorylation of Akt/PKB at
Ser473 in rictor null animals suggests that the embry-
onic lethal phenotype is due, at least in part, to a defect
in Akt/PKB signaling. In mammals, there are three Akt/
PKB isoforms (Akt1/PKBa, Akt2/PKBb, and Akt3/
PKBg) that are encoded by separate genes. Gene tar-
geting studies in mice have indicated that these proteins
play distinct roles (Chen et al., 2001; Cho et al., 2001;Easton et al., 2005; Garofalo et al., 2003; Tschopp
et al., 2005), although, until recently, Akt/PKB was not
considered to be essential for mouse embryogenesis
since single gene disruptions did not cause embryonic
lethality. However, embryonic lethality occurring around
E11–E12 was observed in Akt1/PKBa and Akt3/PKBg
double-knockout animals (Yang et al., 2005). These
animals exhibit developmental defects in the cardiovas-
cular and nervous systems, thereby indicating that
Developmental Cell
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dundant function (Yang et al., 2005). Although mTORC2
almost certainly has other downstream targets (Ali and
Sabatini, 2005), insufficient activity of all three isoforms
of Akt/PKB might be one of factors causing embryonic
lethality in rictor null mice.
Growth factors that activate tyrosine kinase receptors
utilize two major signaling pathways to regulate cell
growth and proliferation: the PI3K-Akt/PKB pathway
and the ras-raf-MAPK pathway (Johnson and Lapadat,
2002). Rictor null MEFs are able to respond to IGF-1 or
PDGF with phosphorylation of p42/44 MAPK, indicating
that the MAPK pathway is not impaired by disruption of
the rictor gene. Furthermore, phosphorylation of S6 ri-
bosomal protein, one of the downstream targets of the
PI3K-Akt/PKB-mTOR pathway, occurs normally in re-
sponse to these growth factors. We did not find differ-
ences between the rictor null and control embryos in
the level of phosphorylation of S6K1 on Thr389, which
is a substrate for mTORC1. In addition, phosphorylation
of GSK3b on Ser9 was rather increased in the rictor null
embryos despite the facts that Akt/PKB is one of ki-
nases for this site and that the in vitro kinase assay
showed decreased Akt/PKB activity in the rictor null
MEFs. These data indicate that partial Akt/PKB activity
may be enough to phosphorylate some targets, or, alter-
nately, that compensatory mechanisms may exist.
rictor null MEFs grew slower in culture than wild-type
MEFs. Furthermore, rictor null MEFs showed lower met-
abolic activity than the wild-type counterpart when
assessed with an XTT assay, which has been reported
to measure redox potential (Berridge et al., 2005). This
finding suggests that other mechanisms for embryonic
lethality in rictor null mice should be considered. For in-
stance, since enhanced cell growth in response to
growth factors increases cellular energy needs, it is pos-
sible that cells lacking rictor may be unable to increase
their energy production, thereby resulting in an intracel-
lular metabolic imbalance and eventual cell death.
mTORC2 Is Not Required for Morphogenesis
during Early Development
InS. cerevisiae, the regulation of actin cytoskeletal orga-
nization appears to be the most important function of
TORC2 (Loewith et al., 2002). It has also been observed
in mammalian cultured cells that disorganization of the
actin cytoskeleton occurs when siRNA is used to knock
down rictor (Jacinto et al., 2004; Sarbassov et al., 2004).
However, we did not observe any remarkable changes
in actin cytoskeleton in rictor null MEFs. While we can-
not explain the differences among groups studying
mammalian cells, the fact that early steps of embryonic
development such as gastrulation, neurulation, and
formation of the cardiovascular system occur normally
in rictor null embryos indicates that mTORC2 is not es-
sential in animals for any of these morphogenic steps,
all of which seem likely to involve changes in the actin
cytoskeleton.
Experimental Procedures
Animals
All animal experiments were performed in accordance with the
guidelines of the Vanderbilt University Institutional Animal Careand Use Committee. Mice used for these studies were of mixed ge-
netic backgrounds and consisted of w87%–94% C57BL/6 and
w6%–13% 129S6. ricw/w, ricEx3cond/w, and ricEx3cond/Ex3cond litter-
mates were used interchangeably as control animals. Ella-cre and
Meox2-cre mice were obtained from Jackson Laboratories. Actin-
Flpe mice were obtained from S. Dymecki (Rodriguez et al., 2000).
Generation of Mouse Embryonic Fibroblasts,
MEFs, and F-Actin Staining
E9.5 embryos were individually washed in PBS and disaggregated
by passage through a 28-gauge needle. The suspension was plated
with Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal
bovine serum (FBS), 100 U/ml penicillin, and 100 mg/ml streptomycin
at 37C in an atmosphere of 5% CO2, and cells were allowed to grow.
After 48 hr, the cells were trypsinized, replated, and designated as
passage 1. For detection of F-actin, MEFs were cultured in a cham-
ber slide (Lab-Tek), fixed with 4% paraformaldehyde at room tem-
perature, permeabilized by 0.1% Triton X-100 in PBS, then stained
with Alexa Fluor 546 phalloidin (Molecular Probes).
Western Blot Analysis
Cells were solubilized in lysis buffer containing 40 mM HEPES (pH
7.5), 120 mM NaCl, 1 mM EDTA, 0.3% CHAPS, protease inhibitors
(cocktail, complete; Roche Applied Science), and phosphatase in-
hibitors (cocktail sets I and II; Calbiochem). For embryo lysates, 6–
10 embryos were pooled and homogenized with a Polytron homog-
enizer in the same lysis buffer. Proteins were separated by NuPAGE
3%–8% Tris-acetate gel (Invitrogen) for mTOR and rictor, or by Nu-
PAGE 10% Bis-Tris gel for the other proteins. Antibodies for mTOR,
phospho-Ser2448 of mTOR, Akt, phospho-Ser473 of Akt, phospho-
Thr308 of Akt, phospho-Ser9 of GSK3b, S6K1, phospho-Thr389 of
S6K1, phospho-Thr202/Tyr204 of p44/42 MAPK, phospho-Ser235/
236 of S6 ribosomal protein, and elF4E were purchased from Cell
Signaling Technology. The antibody for rictor was from purchased
Bethyl Labs, and that for b-tubulin was purchased from Abcam.
Proliferation and Metabolic Activity of MEFs
To quantify MEF proliferation, cells were plated at a density of 4000
cells/well in 96-well plates and were cultured overnight in DMEM
with 0.5% FBS. The cells were then stimulated with FBS or PDGF
for 48 hr and were labeled with BrdU for 2 hr by using a colorimetric
ELISA kit (Roche). MEF metabolic activity was measured by a so-
dium 30-(1-[phenylaminocarbonyl]-3,4-tetrazolium)-bis(4-methoxy-
6-nitro) benzene sulfonic acid hydrate (XTT)-based colorimetric as-
say by using a commercial kit (Roche). Cells were plated in 96-well
plates and were allowed to adhere for 2 hr. XTT labeling was per-
formed for 4 hr before measurement.
In Vitro Kinase Assay
For Akt/PKB kinase assay, cells were cultured overnight without
FBS and were harvested before or after serum stimulation (20%)
for 10 min. The assay was performed by using a commercial kit
(Cell Signaling) that involved a nonradioactive detection method
for phosphorylated substrates.
Supplemental Data
Supplemental Data include Supplemental Experimental Proce-
dures, Supplemental Results (two figures and three tables), and
Supplemental References and are available at http://www.
developmentalcell.com/cgi/content/full/11/4/583/DC1/.
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